Sporadic phaeochromocytoma are rarely associated with germline mutations in the von Hippel-Lindau and RET genes

Clinical Endocrinology

Volumn 47, Issue 6, 1997, Pages 707-712

  Bar, Merav ^a   Friedman, Eitan ^b   Jakobovitz, Orit ^b   Leibowitz, Gil ^a   Lerer, Israela ^a   Abeliovich, Dvorah ^a   Gross, David J ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SIPPLE SYNDROME; VON HIPPEL LINDAU DISEASE; DNA SEQUENCE; GENETICS; MIDDLE AGED; MUTATION; SINGLE STRAND CONFORMATION POLYMORPHISM;

DROSOPHILA PROTEIN; ONCOPROTEIN; PROTEIN RET; PROTEIN TYROSINE KINASE; RET ONCOGENE PROTEIN, DROSOPHILA;

ADOLESCENT; ADULT; DROSOPHILA PROTEINS; FEMALE; GERM-LINE MUTATION; HIPPEL-LINDAU DISEASE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHEOCHROMOCYTOMA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; SEQUENCE ANALYSIS, DNA;

EID: 0031298741     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.3251150.x     Document Type: Article

References (33)

1. Atuk, N.O., McDonald, T., Wood, T., Carpenter, J.T., Walzak, M.P., Donaldson, M. & Gillenwater, J.Y. (1979) Familial pheochromocytoma, hypercalcemia, and von Hippel-Lindau disease. A ten year study of a large family. Medicine, 58, 209-218.
2. Beldjord, C., Desclaux-Arramand, F., Raffin-Sanson, M., Corvol, J.-C., De Keyser, Y., Luton, J.-P., Pluin, P.-F. & Bertagna, X. (1995) The RET protooncogene in sporadic pheochromocytomas: Frequent MEN-2-like mutations and new molecular defects. Journal of Clinical Endocrinology and Metabolism, 80, 2063-2068.
3. Brauch, H., Kishida, T., Glavac, D., Chen, F., Pausch, F., Hofler, H., Latif, F., Lerman, M.I., Zbar, B. & Neumann, H.P. (1995) Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Human Genetics, 95, 551-556.
4. Calmettes, C., Rosenberg Gourgin, M., Caron, J. & Feingold, N. (1992) Pheochromocytoma: a frequent indicator for MEN 2. Henry Ford Hospital Medical Journal, 40, 276-277.
5. Casanova, S., Rosenberg Bourgin, M., Farkas, D., Calmettes, C., Feingold, N., Heshmati, H.M., Cohen, R., Conte Devolx, B., Guillausseau, P.J., Houdent, C., Bigorgne, J.C., Boiteau, V., Caron, J. & Modigliani, E. (1993) Phaeochromocytoma in multiple endocrine neoplasia type 2 A: survey of 100 cases. Clinical Endocrinology, 38, 531-537.
6. Chen, F., Kishida, K., Yao, M., Hustad, T., Glavac, D., Dean, M., Gnarra, J.R., Orcutt, M.L., Duh, F.M., Glenn, G., Green, J., Hsia, Y.E., Lamiell, J., Li, H., Wei, M.W., Schmidt, L., Tory, K., Kuzmin, I., Stackhouse, T., Latif, F., Linehan, W.M., Lerman, M. & Zbar, B. (1995) Germline mutations in the von Hippel-Lindau disease tumour suppressor gene: Correlations with phenotype. Human Mutation, 5, 66-75.
7. Chew, S.L., Dacie, J.E., Reznek, R.H., Newbould, E.C., Sheaves, R., Trainer, P.J., Lowe, D.G., Shand, W.S., Hungerford, J., Besser, G.M. & Grossman, A. (1994) Bilateral phaeochromocytomas in von Hippel-Lindau disease: diagnosis by adrenal vein sampling and catecholamine assay. Quarterly Journal of Medicine, 87, 49-54.
8. Choyke, P.L., Glenn, G.M., Walther, M.M., Patronas, N.J., Linehan, W.M. & Zbar, B. (1995) von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology, 194, 629-642.
9. Crossey, P.A., Eng, C., Ginalska Malinowska, M., Lennard, T.W., Wheeler, D.C., Ponder, B.A. & Maher, E.R. (1995) Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. Journal of Medical Genetics, 32, 885-886.
10. Crossey, P.A., Richards, F.M., Foster, K., Green, J.S., Prowse, A., Latif, F., Lerman, M.I., Zbar, B., Affara, N.A., Ferguson-Smith, M.A. & Maher, E.A. (1994) Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Human Molecular Genetics, 3, 1303-1308.
11. DeAngelis, L.M., Kelleher, M.B., Post, K.D. & Fetell, M.R. (1987) Multiple paragangliomas in neurofibromatosis: a new neuroendocrine neoplasia. Neurology, 37, 129-133.
12. Donis Keller, H., Dou, S., Chi, D., Carlson, K.M., Toshima, K., Lairmore, T.C., Howe, J.R., Moley, J.F., Goodfellow, P. & Wells, S.A. Jr (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics, 2, 851-856.
13. Eng, C., Crossey, P.A., Mulligan, L.M., Healey, C.S., Houghton, C., Prowse, A., Chew, S.L., Dahia, P.L.M., O'Riordan, J.L.H., Toledo, S.P.A., Smith, D.P., Maher, E.R. & Ponder, B.A.J. (1995) Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. Journal of Medical Genetics, 32, 934-937.
14. Garcia, A., Matias-Guiu, X., Cabezas, R., Chico, A., Prat, J., Baiget, M. & De Leiva, A. (1997) Molecular diagnosis of von Hippel-Lindau disease in a kindred with a predominance of phaeochromocytoma. Clinical Endocrinology, 46, 359-363.
15. Gross, D.J., Naaman, A., Filon, D., Meiner, V., Zbar, B. & Abeliovitch, D. (1996) Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. Journal of Clinical Endocrinology and Metabolism, 81, 147-149.
16. Komminoth, P., Roth, J., Muletta-Feurer, S., Saremaslani, P., Seelentag, W.K.F. & Heitz, P.U. (1996) RET proto-oncogene point mutations in sporadic neuroendocrine tumors. Journal of Clinical Endocrinology and Metabolism, 81, 2041-2046.
17. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.M., Orcutt, M.L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhon, F., Li, H., Wei, M.H., Chen, F., Glenn, G., Choyke, P., Walther, M.M., Weng, Y., Duan, D.R., Dean, M., Glavac, D., Richards, F.M., Crossey, P.A., Ferguson-Smith, M.A., Le Paslier, D., Chumakov, I., Cohen, D., Chinault, C.A., Maher, E.R., Linehan, W.M., Zbar, B. & Lerman, M.I. (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 260, 1317-1320.
18. Lerman, L.S., Fischer, S.G., Hurley, I., Silverstein, K. & Lumelsky, N. (1984) Sequence-determined DNA separations. Annual Review of Biophysics and Bioengineering, 13, 399-423.
19. Lindor, N.M., Honchel, R., Khosla, S. & Thibodeau, S.N. (1995) Mutations in the RET protooncogene in sporadic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism, 80, 627-629.
20. Maher, E.R., Yates, J.R., Harries, R., Benjamin, C., Harris, R., Moore, A.T. & Ferguson Smith, M.A. (1990) Clinical features and natural history of von Hippel-Lindau disease. Quarterly Journal of Medicine, 77, 1151-1163.
21. Myers, R.M., Maniatis, T. & Lerman, L.S. (1987) Detection and localization of single base changes by denaturing gradient gel electrophoresis. In Methods in Enzymology, Vol. 155 (ed R. Wu), pp. 501-527. Academic Press, San Diego.
22. Neumann, H.P., Berger, D.P., Sigmund, G., Blum, U., Schmidt, D., Parmer, R.J., Volk, B. & Kirste, G. (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. New England Journal of Medicine, 329, 1531-1538.
23. Neumann, H.P., Eng, C., Mulligan, L.M., Glavac, D., Zäuner, L. Ponder, B.A.J., Crossey, P.A., Maher, E.R. & Brauch, H. (1995) Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. Journal of the American Medical Association, 274, 1149-1151.
24. Orita, M., Suzuki, Y., Sekiya, T. & Hayashi, K. (1989) Rapid and sensitive detection of point imitations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5, 874-879.
25. Proye, C.A., Vix, M., Jansson, S., Tisell, L.E., Dralle, H. & Hiller, W. (1994) 'The' pheochromocytoma: a benign, intra-adrenal, hypertensive, sporadic unilateral tumor. Does it exist? World Journal of Surgery, 18, 467-472.
26. Raue, F., Frank Raue, K. & Grauer, A. (1994) Multiple endocrine neoplasia type 2. Clinical features and screening. Endocrinology and Metabolism Clinics of North America, 23, 137-156.
27. Richard, S., Beigelman, C., Duclos, J.M., Fendler, J.P., Plauchu, H., Plouin, P.F., Resche, F., Schlumberger, M., Vermesse, B. & Proye, C. (1994) Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery, 116, 1076-1081.
28. Richards, F.M., Crossey, P.A., Phipps, M.E., Foster, K., Latif, F., Evans, G., Sampson, J., Lerman, M.I., Zbar, B., Affara, N.A., Ferguson-Smith, M.A. & Maher, E.R. (1994) Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Human Molecular Genetics, 3, 595-598.
29. Ritter, M.M., Frilling, A., Crossey, P.A., Hoppner, W., Maher, E.R., Mulligan, L., Ponder, B.A.J. & Engelhardt, D. (1996) Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. Journal of Clinical Endocrinology and Metabolism, 81, 1035-1037.
30. van Heyningen, V. (1994) One gene-four syndromes. Nature, 367, 319-320.
31. Winship, P.R. (1989) An improved method for direct sequencing PCR amplified material using dimethyl sulfoxide. Nucleic Acid Research, 17, 1266.
32. Zbar, B., Kishida, T., Chen, F., Schmidt, L., Maher, E.R., Richards, F.M., Crossey, P.A., Webster, A., Affara, N.A., Ferguson-Smith, M.A., Brauch, H., Neumann, H., Tisherman, S., Mulvihill, J.J., Gross, D.J., Shuin, T., Whaley, J., Seizinger, B., Kley, N., Olschwang, S., Boisson, S., Richard, S., Lips, C.H.M., Linehan, W.M. & Lerman, M. (1996) Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America. Europe and Japan. Human Mutation, 8, 348-357.
33. Zedenius, J., Wallin, G., Hamberger, B., Nordenskjold, M., Weber, G. & Larsson, C. (1994) Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s. Human Molecular Genetics, 3, 1259-1262.